As the high predictive value of stress hyperglycemia for the prognosis of AMI may be related to its effects on myocardial metabolism and insulin treatment for DM [7, 8], we also evaluated the predictive potential of the SHR in STEMI patients without diabetes (nondiabetic subgroup). This evidence concerns the gene INS and Hyperglycemia.